India's Pharmaceutical Exports

Country Profile

Bhutan

Bhutan is an emerging destination for Indian pharmaceutical exports — $8.97M in FY 2025–26, with 3.4× growth over the past decade. Medicines accounts for 55% of shipments, with vaccines contributing $366K. The compound annual growth rate since FY2015 stands at 11.8%.

🇧🇹 $8.97M · 3.4× growth since FY2015 · 11.8% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$8.97M
Exports FY2025–26 DGCIS
3.4×
Growth FY2015→2026
11.8%
CAGR FY2015→2026
55%
Medicines Share
5
Product Categories Supplied
Bhutan is an emerging destination for Indian pharmaceutical exports — $8.97M in FY 2025–26, with 3.4× growth over the past decade. Medicines accounts for 55% of shipments, with vaccines contributing $366K. The compound annual growth rate since FY2015 stands at 11.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $4.95M (55.3%) Surgical & Hospital Supplies $2.32M (25.9%) Medicine Ingredients $940K (10.5%) Traditional & Herbal $383K (4.3%) Vaccines $366K (4.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Bhutan in the RBI overseas direct investment dataset (2011–2026).